Informations sur le produit
- 2-Butenoicacid, 2-methyl-,5,6,7,8-tetrahydro-2,3-dimethoxy-6,7-dimethyl-1-oxo-1H,14H-benzo[1,8]cycloocta[1,2,3-cd][1,3]dioxolo[4,5-g]benzofuran-8-ylester, [6R-[6a,7a,8a(Z),14aS*]]-
- 1H,14H-Benzo[1,8]cycloocta[1,2,3-cd][1,3]dioxolo[4,5-g]benzofuran, 2-butenoicacid deriv.
- (-)-Heteroclitin D
Heteroclitin D is a sesquiterpene lactone from the plant Fructus heterocliti. It is an inhibitor of ATP-sensitive K+ channels and has been shown to inhibit cancer cell growth in vitro. Heteroclitin D has been shown to have pharmacokinetics properties that are linear over a wide range of doses, which makes it an efficient method for drug development. It also inhibits L-type calcium currents and causes a reduction in the number of cancer cells, suggesting a potential use as an anticancer agent.